A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
Forbes | A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.
See how we're leveraging our rich data sets to uncover new oncology insights.
Financial Times | Premier's Roni Christopher weighs in on the FDA's approval of a Biogen treatment for patients with Alzheimer's disease.
Premier Applied Sciences to analyze study results and evaluation of the product aimed at improving outcomes and lowering costs for male urinary disorders.
Mike Alkire and Diana Brainard, SVP and Virology Therapeutic Area Head at Gilead, talk about launching a new therapy during COVID-19.
The Executive Director at NYC Hospitality Alliance discusses similarities between the restaurant biz and healthcare.
Chrissy Farr, Principal at OMERS Ventures along with guest co-host Dr. Jonathan Slotkin, Chief Medical Officer at Contigo Health a Premier company, talk about all...
Carla Tardif, CEO and founder of Family Reach, as well as Yousuf Zafar, MD, Chief Quality and Innovation Officer at Duke Cancer Institute, discuss the...
JAMA Network | This paper examines the uptake and accuracy of diagnosis for COVID-19 in U.S. hospitals.